Global Osteoarthritis Therapeutics Market 2021: Top Industry Players, Growth Report to 2027

The global osteoarthritis therapeutics market is estimated to grow at a CAGR of 8.2% during the forecast period. Pipeline products are expected to offer an opportunity for the growth of the market. For instance, in April 2019, Pfizer Inc. and Eli Lilly and Co. declared a Phase III study outcomes assessing tanezumab 2.5 mg and 5 mg. This study was intended to compare the 16-week efficacy of tanezumab and long-term joint safety relative to nonsteroidal anti-inflammatory drugs (NSAIDs) among patients with moderate-to-severe osteoarthritis of the knee or hip. 5 mg treatment arm of the tanezumab met two from the three co-primary endpoints related to efficacy, showing a statistically potential improvement in physical function and pain than NSAIDs at the 16-week analysis.

(Get 15% Discount on Buying this Report)

Get Report Sample Copy @ https://www.omrglobal.com/request-sample/osteoarthritis-therapeutics-market

However, patients who received 2.5 mg tanezumab did not experience a statistically potential improvement in physical function, pain, or overall assessment of patients for their osteoarthritis at 16 weeks than NSAIDs. Under the analysis for safety, there was a potential rate of events regarding joint safety in the tanezumab arms than NSAIDs at 80 weeks. As a monoclonal antibody, Tanezumab is part of an investigational drug class of non-opioid chronic pain medications referred to as nerve growth factor (NGF) inhibitors. These kinds of pipeline products with increased safety and efficacy are expected to offer an opportunity for the launch of new therapies in the future, which in turn, will likely drive the market growth.

A Full Report of Global Osteoarthritis Therapeutics Market is Available at: https://www.omrglobal.com/industry-reports/osteoarthritis-therapeutics-market

Scope of the Global Osteoarthritis Therapeutics Market

Market Coverage

Market number available for 2019-2026
Base year- 2019
Forecast period- 2020-2026
Segment Covered- By Anatomy and Drug Type
Regions Covered- North America, Europe, Asia-Pacific, and Rest of the World
Competitive Landscape- Pfizer Inc., Bayer AG, Zimmer Biomet Holdings, Inc., Sanofi S.A., and GlaxoSmithKline plc

Global Osteoarthritis Therapeutics Market-Segmentation

By Anatomy

Knee
Ankle
Hip
Hand
Spine

By Drug Type

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
Viscosupplementation Agents
Corticosteroids
Analgesics

Global Osteoarthritis Therapeutics Market– Segment by Region

North America

United States
Canada

Europe

UK
Germany
Italy
Spain
France
Rest of Europe

Asia-Pacific

China
India
Japan
South Korea
Rest of Asia-Pacific

Rest of the World

Reasons to Buying From us –

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/osteoarthritis-therapeutics-market

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.